iKang Group Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Go Beyond the Preview-Access the Full Value Chain Analysis
This iKang Group Value Chain Analysis shows how the company creates value through its support and primary activities in a clear, practical framework. The page already includes a real preview of the analysis, so you can review the actual content and format before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Firm Infrastructure
In 2025, iKang Group's firm infrastructure centers on corporate leadership that manages a decentralized network of more than 160 specialized centers across China, with tight financial controls and legal compliance.
By centralizing oversight of these capital-heavy medical assets, iKang Group keeps capital allocation stable and aligned with long-term strategy, which suits investors focused on durable cash use.
This setup also helps standardize governance, reduce control gaps, and support consistent execution across a nationwide healthcare platform.
Human Resource Management
In iKang Group's 2025 value chain, human resource management centers on recruiting licensed physicians and specialized radiologists to protect diagnostic accuracy and brand trust. Training also pushes patient-first care and mastery of the iKang AI+ software suite, which helps keep service standards uniform across sites.
Technology Development
iKang Group's Technology Development centers on its proprietary AI+ engine, which applies artificial intelligence to diagnostic imaging for earlier oncology and cardiovascular detection. Cancer caused about 9.7 million deaths worldwide in 2022, and cardiovascular disease about 19.8 million, so faster screening can matter at scale.
Its secure cloud platform supports large health-data aggregation, which improves model training and helps deliver more personal wellness advice. In 2025, this kind of data layer is a core cost and quality driver because the AI market keeps shifting from pilots to repeatable clinical use.
Procurement
iKang Group's procurement depends on scale buying and vendor ties with GE HealthCare and Siemens to lock in MRI and CT systems at better prices, which helps keep capex and unit economics in check. Bulk sourcing of lab reagents and medical consumables lowers per-test costs and supports steady margins across its clinic network. This matters because imaging and lab inputs are a core cost line in diagnostic chains.
iKang's 160+ Center Network Stays Lean with AI and Supplier Ties
In 2025, iKang Group's support activities keep a nationwide diagnostic chain running by coordinating leadership, licensed staff, AI tools, and supplier contracts across 160+ centers in China.
That mix helps hold quality steady, protect data, and control capex and test costs.
| Support area | 2025 signal |
|---|---|
| Network | 160+ centers |
| AI | AI+ imaging |
| Supply | GE HealthCare, Siemens |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
iKang Group's inbound logistics depends on tight coordination with global pharma and medical supply chains, keeping fresh reagents and consumables flowing to its internal labs. Its cold-chain handling protects temperature-sensitive diagnostic kits as they move through a network spanning 50+ cities, which helps cut spoilage and test delays. For a lab network at this scale, fast, controlled intake is a direct input to service quality and throughput.
Operations
Operations at iKang Group center on high-throughput patient flow, with 360-degree routing that cuts bottlenecks during physical exams and diagnostic testing. In-house laboratories process samples fast, and automated data entry turns raw test results into clinical profiles with less manual work and fewer errors. That setup supports faster turnaround and steadier exam volume handling.
Outbound Logistics
iKang Group's outbound logistics is digital, not physical: after a visit, health reports are pushed to the consumer's smartphone app within 24 to 48 hours, which cuts delivery time and speeds follow-up care. Secure data warehousing then stores electronic medical records for long-term access, so the same patient can track results across years and stay inside the ecosystem. This data layer supports repeat testing, higher retention, and more cross-sell opportunities.
Marketing and Sales
iKang Group's B2B sales team targets more than 30,000 corporate clients, from small firms to global groups, to lock in annual health check contracts. Tiered pricing and custom screening bundles let Company Name match budgets and risk needs across income bands and sectors. That model supports repeat revenue and helps Company Name win share in a market where employers keep pushing preventive care.
Service
Service is a key primary activity for iKang Group because post-examination consultations give patients same-day face-to-face feedback, help explain high-risk results, and set the next care step. The Green Channel referral service also adds value by linking screening clients to major public hospitals, which shortens the move from diagnosis to treatment. In China's high-volume health check market, this follow-up layer helps convert screening into real medical action and supports retention.
iKang's Scale, Speed, and Repeat Care Drive Its Business Model
iKang Group's primary activities run from supplier intake to testing, report delivery, and aftercare. Its lab and clinic network spans 50+ cities, with 24-48 hour digital report delivery and service to 30,000+ corporate clients, so volume and speed stay central to the model.
| Primary activity | Key 2025 metric |
|---|---|
| Operations | 50+ cities |
| Outbound logistics | 24-48 hours |
| B2B sales | 30,000+ clients |
Same-day consults and Green Channel referrals turn screening into follow-up care, which supports retention and repeat exams.
Get Your Copy
iKang Group Reference Sources
You're viewing the actual iKang Group Value Chain Analysis document, not a sample. The preview below is taken directly from the full report you'll receive after purchase. Once payment is completed, you'll unlock the complete, detailed version with no surprises.
Frequently Asked Questions
iKang leverages a massive network of 160-plus diagnostic centers to deliver preventive screenings. Its operations focus on a standardized patient flow and 24-hour lab turnaround times. These core activities are supported by more than 2,500 certified medical professionals who ensure each screening adheres to rigorous quality control benchmarks across mainland China's diverse and expanding health markets.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.